Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Diabetes Care - United States
doi 10.2337/dc06-0703
Full Text
Open PDFAbstract
Available in full text
Date
November 27, 2006
Authors
Publisher
American Diabetes Association